九安医疗: 第六届监事会第二十次会议决议公告

Core Viewpoint - The company has approved a proposal to change the purpose of part of the repurchased shares and to cancel them, which aligns with relevant regulations and does not harm the interests of the company or its shareholders [1][2]. Group 1: Meeting Details - The sixth session of the 20th meeting of the Supervisory Board was held on September 5, 2025, with all three attending supervisors present [1]. - The meeting was chaired by Mr. Yao Kai, the chairman of the Supervisory Board, and complied with the legal and regulatory requirements [1]. Group 2: Proposal Approval - The proposal to change the purpose of part of the repurchased shares and to cancel them was approved with a unanimous vote of 3 in favor, 0 against, and 0 abstentions [1]. - The Supervisory Board concluded that the change complies with the regulations regarding share repurchase and does not negatively impact the company's financial, operational, research, or debt obligations [1]. Group 3: Impact on Company - The cancellation of the repurchased shares will not affect the company's control or its compliance with listing conditions, ensuring that the company's listing status remains intact [1]. - The proposal is subject to approval by the shareholders' meeting before implementation [2].